Rebecca Waldeck
Adult Health · Cleveland, OHNPI 1013410745
Payments from drug & device makers
Across 56 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$281
- Novartis$179
- AstraZeneca$173
- Merck$127
- Genentech USA, Inc.$85
- Bayer$74
- plus $408 from 14 others
What the payments were for
- Food & beverage$1,327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $281 |
| Novartis | 9 | $179 |
| AstraZeneca(2 entities) | 9 | $173 |
| Merck | 6 | $127 |
| Genentech USA, Inc. | 5 | $85 |
| Bayer | 4 | $74 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Sanofi | 2 | $45 |
| Morphosys, US Inc. | 2 | $44 |
| Rigel Pharmaceuticals, Inc. | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Incyte Corporation | 2 | $32 |
| Coherus Oncology, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| AbbVie | 1 | $21 |
| Seagen Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Geron Corporation | 1 | $17 |
| Pfizer | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$281
How this compares
$1,327 in reported general payments places this provider in the 75th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 72 | $74,237 |
| Xtampza ErOxycodone Myristate | 26 | $16,259 |
| Fentanyl | 138 | $15,805 |
| Oxycodone Hcl | 380 | $10,740 |
| Morphine Sulfate ErMorphine Sulfate | 224 | $5,670 |
| Ondansetron Hcl | 31 | $4,246 |
| Gabapentin | 179 | $3,611 |
| Ondansetron OdtOndansetron | 76 | $3,094 |
| Morphine Sulfate | 51 | $2,403 |
| Duloxetine Hcl | 101 | $2,021 |
| Scopolamine | 13 | $1,707 |
| Olanzapine | 68 | $1,288 |
| Pilocarpine Hcl | 16 | $1,030 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $839 |
| Lactulose | 29 | $791 |
Paid to pharmacies, not to this prescriber.
Other adult health in Cleveland
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
- Kathleen HarrisCleveland$28K
- Mindy RiveraCleveland$20K
- Elizabeth CrespoCleveland$12K
- Amanda BonhamCleveland$7K
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.